SB2013 L08gr01: Difference between revisions

Line 29:

== References ==

1.

1.Dressler F, Whalen J, Reinhardt B, Steere A. Western blotting in the serodiagnosis of Lyme disease. 1993. J Clin Microbiol. Vol. 167. 8 p.

2.Fung B, McHugh G, Leong J, Steere A. Humoral immune response to outer surface protein C of Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the serodiagnosis of early infection. 1994. Infection and Immunity. Vol. 62. 8 p.

3.Gilmore R, Kappel K, Dolan M, Burkot T, Johnson B. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. 1996. Infection and Immunity.

4.Greenberg, D. (2001, February 28). Brookhaven scientists determine key Lyme disease protein structure. Retrieved from http://www.bnl.gov/bnlweb/pubaf/pr/2001/bnlpr022801.htm

5.Jobe D, Lovrich S, Schell R, Callister S. C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease. 2003. Clin Vaccine Immuno.Vol. 10. 5 p.

6.Kumaran D, Eswaramoorthy S, Luft B, Koide S, Dunn J, Lawson C, Swaminathan S. 2001. Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete,Borrelia burgdorferi. The EMBO Journal: United Kingdom. Vol. 20, No. 5. 8 p.Vol. 64, No.6.5.

7.Lovrich S, Jobe D, Schell R, Callister S. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human Lyme disease and do not occur in mice or hamsters. 2005. Clin Vaccine Immuno. Vol. 12. 6 p.

8.Mbow M, Gilmore R, Titus R. An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. 1999. Infection and Immunity. Vol. 67. 2 p.

9.Önder O, Humphrey PT, McOmber B, Korobova F, Francella N, Greenbaum DC, Brisson D.OspC Is Potent Plasminogen Receptor on Surface of Borrelia burgdorferi. 2011. The

10.Wilske B, Preac-Mursic V, Schierz G, Busch K. Immunochemical and immunological analysis of European Borrelia burgdorferi strains. 1986. Zentralbl Bakteriol Mikrobiol Hyg A. Vol. 263, No. 1-2. 10 p.

11.Zhong W, Gern L, Stehle T. Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC. 1999. Eur. J. Immunol. Vol. 29, No. 3. 2 p.

SB2013 L08gr01: Difference between revisions

Navigation menu

Page actions

Page actions

Personal tools

Navigation

Search

Tools

@@ Line 29: / Line 29: @@
 == References ==
-.
+.Dressler F, Whalen J, Reinhardt B, Steere A. Western blotting in the serodiagnosis of Lyme	disease. 1993. J Clin Microbiol. Vol. 167. 8 p.
+.Fung B, McHugh G, Leong J, Steere A. Humoral immune response to outer surface protein C of	Borrelia burgdorferi in Lyme disease: role of the immunoglobulin M response in the	serodiagnosis of early infection. 1994. Infection and Immunity. Vol. 62. 8 p.
+.Gilmore R, Kappel K, Dolan M, Burkot T, Johnson B. Outer surface protein C (OspC), but not	P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge:	evidence for a conformational protective epitope in OspC. 1996. Infection and Immunity.
+.Greenberg, D. (2001, February 28). Brookhaven scientists determine key Lyme disease protein	structure. Retrieved from http://www.bnl.gov/bnlweb/pubaf/pr/2001/bnlpr022801.htm
+.Jobe D, Lovrich S, Schell R, Callister S. C-terminal region of outer surface protein C binds	borreliacidal antibodies in sera from patients with Lyme disease. 2003. Clin Vaccine	Immuno.Vol. 10. 5 p.
+.Kumaran D, Eswaramoorthy S, Luft B, Koide S, Dunn J, Lawson C, Swaminathan S. 2001.	Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete,Borrelia burgdorferi. The EMBO Journal: United Kingdom. Vol.  20, No. 5. 8 p.Vol. 64, No.6.5.
+.Lovrich S, Jobe D, Schell R, Callister S. Borreliacidal OspC antibodies specific for a highly	conserved epitope are immunodominant in human Lyme disease and do not occur in mice	or hamsters. 2005. Clin Vaccine Immuno. Vol. 12. 6 p.
+.Mbow M, Gilmore R, Titus R. An OspC-specific monoclonal antibody passively protects mice from tick-transmitted infection by Borrelia burgdorferi B31. 1999. Infection and	Immunity. Vol. 67. 2 p.
+.Önder O, Humphrey PT, McOmber B, Korobova F, Francella N, Greenbaum DC, Brisson D.OspC Is Potent Plasminogen Receptor on Surface of Borrelia burgdorferi. 2011. The
+.Wilske B, Preac-Mursic V, Schierz G, Busch K. Immunochemical and immunological analysis	of European Borrelia burgdorferi strains. 1986. Zentralbl Bakteriol Mikrobiol Hyg A.	Vol. 263, No. 1-2. 10 p.
+.Zhong W, Gern L, Stehle T. Resolution of experimental and tick-borne Borrelia burgdorferi	infection in mice by passive, but not active immunization using recombinant OspC. 1999.	Eur. J. Immunol. Vol. 29, No. 3. 2 p.